Skip to content
    Vertex Pharmaceuticals logo

    Vertex Pharmaceuticals

    Boston, Massachusetts, United StatesFounded 1989
    www.vrtx.comLinkedIn
    Biotech & Life SciencesHealthcare

    Vertex Pharmaceuticals is a global biopharmaceutical company based in Boston, Massachusetts, focused on discovering, developing, and commercializing transformative medicines for serious diseases such as cystic fibrosis, sickle cell disease, and pain. The company invests in scientific innovation and has made strategic acquisitions and investments in biotech companies.

    60% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (80% of deals). Average disclosed round size is $137.1M (across 4 rounds with reported amounts).

    Find people at Vertex Pharmaceuticals on Goldilocks AI

    Portfolio

    5

    Fund Size

    —

    Top Stage

    Series B

    Last 12 Mo

    0

    Team

    AG

    Alan Garber

    Director

    BS

    Bruce Sachs

    Director

    DM

    Diana McKenzie

    Director

    JL

    Jeffrey Leiden

    Director

    JS

    Jennifer Schneider

    Director

    LC

    Lloyd Carney

    Director

    ML

    Michel Lagarde

    Director

    NT

    Nancy Thornberry

    Director

    RK

    Reshma Kewalramani

    Director

    SB

    Sangeeta Bhatia

    Director

    AK

    Amit K. Sachdev

    Executive Vice President, Chief Patient and External Affairs Officer

    CW

    Charles Wagner

    Executive Vice President and Chief Operating & Financial Officer

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    5 investments
    CompanyRoundAmountDate
    Stackwell logoStackwellSeed$3.5MAug 2022
    Arbor Biotechnologies logoArbor BiotechnologiesSeries B$215MNov 2021
    Obsidian Therapeutics logoObsidian TherapeuticsSeries B$115MSep 2021
    AArbor BiotechnologiesSeries B$215MJan 2021
    Genomics logoGenomicsSeries B——

    Top Co-Investors

    Logos Capital3 shared
    Surveyor Capital3 shared
    Deep Track Capital3 shared
    Temasek Holdings (Private) Limited2 shared
    Tao Capital Partners2 shared
    Illumina Ventures2 shared
    Tekla Capital Management2 shared
    T. Rowe Price2 shared
    Section 322 shared
    ARCH Venture Partners2 shared
    Ono Venture Investment2 shared
    TCG Crossover2 shared
    Piper Heartland Healthcare Capital2 shared
    Ally Bridge Group2 shared
    ArrowMark Partners2 shared
    Ridgeback Capital2 shared
    Scale Venture Partners1 shared
    CMFG Ventures Discovery Fund1 shared
    Nexus Venture Partners1 shared
    Service Provider Capital1 shared

    Last updated: 19 September 2026